{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:14:35Z","timestamp":1792181675187,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Institut Pasteur"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-022-01281-y","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:04:38Z","timestamp":1672938278000},"page":"64-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8508-5167","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Reynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-1675","authenticated-orcid":false,"given":"Xavier","family":"Carnec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-3900","authenticated-orcid":false,"given":"Caroline","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Borges-Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Journeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-0245","authenticated-orcid":false,"given":"Mathieu","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Hortion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-5908","authenticated-orcid":false,"given":"Emeline","family":"Perthame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pietrosemoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Vallv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Duthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Jourjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Moroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyne","family":"Fellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henri","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eflys","family":"Daniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Legras-Lachuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Dirheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Carbonnelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-3255","authenticated-orcid":false,"given":"Herv\u00e9","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3234-7477","authenticated-orcid":false,"given":"Sylvain","family":"Baize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"1281_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/viro.2001.0874","volume":"283","author":"RN Charrel","year":"2001","unstructured":"Charrel, R. N., de Lamballerie, X. & Fulhorst, C. F. The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae). Virology 283, 161\u2013166 (2001).","journal-title":"Virology"},{"key":"1281_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2011.07.014","volume":"14","author":"H Choe","year":"2011","unstructured":"Choe, H., Jemielity, S., Abraham, J., Radoshitzky, S. R. & Farzan, M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Curr. Opin. Microbiol. 14, 476\u2013482 (2011).","journal-title":"Curr. Opin. Microbiol."},{"key":"1281_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4161\/hv.7.6.15198","volume":"7","author":"A Ambrosio","year":"2011","unstructured":"Ambrosio, A., Saavedra, M., Mariani, M., Gamboa, G. & Maiza, A. Argentine hemorrhagic fever vaccines. Hum. Vaccin. 7, 694\u2013700 (2011).","journal-title":"Hum. Vaccin."},{"key":"1281_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","volume":"78","author":"DA Enria","year":"2008","unstructured":"Enria, D. A., Briggiler, A. M. & S\u00e1nchez, Z. Treatment of Argentine hemorrhagic fever. Antiviral Res. 78, 132\u2013139 (2008).","journal-title":"Antiviral Res."},{"key":"1281_CR5","first-page":"215","volume":"70","author":"DA Enria","year":"2010","unstructured":"Enria, D. A. et al. Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety [in Spanish]. Medicina (B. Aires) 70, 215\u2013222 (2010).","journal-title":"Medicina (B. Aires)"},{"key":"1281_CR6","doi-asserted-by":"publisher","first-page":"10404","DOI":"10.1128\/JVI.00856-11","volume":"85","author":"CG Albari\u00f1o","year":"2011","unstructured":"Albari\u00f1o, C. G. et al. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J. Virol. 85, 10404\u201310408 (2011).","journal-title":"J. Virol."},{"key":"1281_CR7","doi-asserted-by":"publisher","first-page":"e01682-17","DOI":"10.1128\/JVI.01682-17","volume":"92","author":"J York","year":"2017","unstructured":"York, J. & Nunberg, J. H. Epistatic interactions within the Jun\u00edn virus envelope glycoprotein complex provide an evolutionary barrier to reversion in the live-attenuated Candid#1 vaccine. J. Virol. 92, e01682-17 (2017).","journal-title":"J. Virol."},{"key":"1281_CR8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3201\/eid1509.090017","volume":"15","author":"PV Aguilar","year":"2009","unstructured":"Aguilar, P. V. et al. Reemergence of Bolivian hemorrhagic fever, 2007\u20132008. Emerg. Infect. Dis. 15, 1526\u20131528 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"1281_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coviro.2014.02.007","volume":"5","author":"M Patterson","year":"2014","unstructured":"Patterson, M., Grant, A. & Paessler, S. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr. Opin. Virol. 5, 82\u201390 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"1281_CR10","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1016\/j.vaccine.2020.02.053","volume":"38","author":"DM Johnson","year":"2020","unstructured":"Johnson, D. M. et al. Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector. Vaccine 38, 2949\u20132959 (2020).","journal-title":"Vaccine"},{"key":"1281_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/JVI.02615-15","volume":"90","author":"T Koma","year":"2015","unstructured":"Koma, T. et al. Machupo virus expressing GPC of the Candid#1 vaccine strain of Junin virus is highly attenuated and immunogenic. J. Virol. 90, 1290\u20131297 (2015).","journal-title":"J. Virol."},{"key":"1281_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0140-6736(94)91226-2","volume":"343","author":"TLM Coimbra","year":"1994","unstructured":"Coimbra, T. L. M. et al. New arenavirus isolated in Brazil. Lancet 343, 391\u2013392 (1994).","journal-title":"Lancet"},{"key":"1281_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4269\/ajtmh.1994.50.452","volume":"50","author":"RB Tesh","year":"1994","unstructured":"Tesh, R. B., Jahrling, P. B., Salas, R. & Shope, R. E. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am. J. Trop. Med. Hyg. 50, 452\u2013459 (1994).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1281_CR14","doi-asserted-by":"publisher","first-page":"e1000047","DOI":"10.1371\/journal.ppat.1000047","volume":"4","author":"S Delgado","year":"2008","unstructured":"Delgado, S. et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 4, e1000047 (2008).","journal-title":"PLoS Pathog."},{"key":"1281_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4269\/ajtmh.1992.47.749","volume":"47","author":"JN Mills","year":"1992","unstructured":"Mills, J. N. et al. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 47, 749\u2013763 (1992).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1281_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4269\/ajtmh.1991.44.589","volume":"44","author":"JN Mills","year":"1991","unstructured":"Mills, J. N. et al. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am. J. Trop. Med. Hyg. 44, 589\u2013597 (1991).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1281_CR17","first-page":"691","volume":"52","author":"R Mercado","year":"1975","unstructured":"Mercado, R. Rodent control programmes in areas affected by Bolivian haemorrhagic fever. Bull. World Health Organ. 52, 691\u2013696 (1975).","journal-title":"Bull. World Health Organ."},{"key":"1281_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/viro.1996.0512","volume":"224","author":"CF Fulhorst","year":"1996","unstructured":"Fulhorst, C. F. et al. Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 224, 114\u2013120 (1996).","journal-title":"Virology"},{"key":"1281_CR19","unstructured":"MMWR Fatal Illnesses Associated with a New World Arenavirus\u2014California, 1999\u20132000 (CDC, 2000)."},{"key":"1281_CR20","doi-asserted-by":"publisher","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","volume":"5","author":"T Briese","year":"2009","unstructured":"Briese, T. et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 5, e1000455 (2009).","journal-title":"PLoS Pathog."},{"key":"1281_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(84)90299-X","volume":"2","author":"DA Enria","year":"1984","unstructured":"Enria, D. A., Briggiler, A. M., Fernandez, N. J., Levis, S. C. & Maiztegui, J. I. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet 2, 255\u2013256 (1984).","journal-title":"Lancet"},{"key":"1281_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jmv.1890200303","volume":"20","author":"RH Kenyon","year":"1986","unstructured":"Kenyon, R. H., Green, D. E., Eddy, G. A. & Peters, C. J. Treatment of Junin virus-infected guinea pigs with immune serum: development of late neurological disease. J. Med. Virol. 20, 207\u2013218 (1986).","journal-title":"J. Med. Virol."},{"key":"1281_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jmv.1890210109","volume":"21","author":"MM Avila","year":"1987","unstructured":"Avila, M. M., Samoilovich, S. R., Laguens, R. P., Merani, M. S. & Weissenbacher, M. C. Protection of Jun\u00edn virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J. Med. Virol. 21, 67\u201374 (1987).","journal-title":"J. Med. Virol."},{"key":"1281_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","volume":"2","author":"JI Maiztegui","year":"1979","unstructured":"Maiztegui, J. I., Fernandez, N. J. & de Damilano, A. J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2, 1216\u20131217 (1979).","journal-title":"Lancet"},{"key":"1281_CR25","doi-asserted-by":"publisher","first-page":"e02230-17","DOI":"10.1128\/JVI.02230-17","volume":"92","author":"X Carnec","year":"2018","unstructured":"Carnec, X. et al. A vaccine platform against arenaviruses based on a recombinant hyperattenuated mopeia virus expressing heterologous glycoproteins. J. Virol. 92, e02230-17 (2018).","journal-title":"J. Virol."},{"key":"1281_CR26","doi-asserted-by":"publisher","first-page":"eaaw3163","DOI":"10.1126\/scitranslmed.aaw3163","volume":"11","author":"M Mateo","year":"2019","unstructured":"Mateo, M. et al. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Sci. Transl. Med. 11, eaaw3163 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1281_CR27","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1128\/JVI.00763-09","volume":"83","author":"L Mart\u00ednez-Sobrido","year":"2009","unstructured":"Mart\u00ednez-Sobrido, L. et al. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83, 11330\u201311340 (2009).","journal-title":"J. Virol."},{"key":"1281_CR28","doi-asserted-by":"publisher","first-page":"16949","DOI":"10.1074\/jbc.M112.420521","volume":"288","author":"X Jiang","year":"2013","unstructured":"Jiang, X. et al. Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J. Biol. Chem. 288, 16949\u201316959 (2013).","journal-title":"J. Biol. Chem."},{"key":"1281_CR29","doi-asserted-by":"publisher","first-page":"e2032","DOI":"10.1371\/journal.pone.0002032","volume":"3","author":"M Habjan","year":"2008","unstructured":"Habjan, M. et al. Processing of genome 5\u2032 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3, e2032 (2008).","journal-title":"PLoS ONE"},{"key":"1281_CR30","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1073\/pnas.1016404108","volume":"108","author":"KM Hastie","year":"2011","unstructured":"Hastie, K. M., Kimberlin, C. R., Zandonatti, M. A., MacRae, I. J. & Saphire, E. O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression. Proc. Natl Acad. Sci. USA 108, 2396\u20132401 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1281_CR31","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.immuni.2015.11.012","volume":"43","author":"HI Nakaya","year":"2015","unstructured":"Nakaya, H. I. et al. Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity 43, 1186\u20131198 (2015).","journal-title":"Immunity"},{"key":"1281_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijid.2021.02.046","volume":"105","author":"MG Frank","year":"2021","unstructured":"Frank, M. G. et al. South American hemorrhagic fevers: a summary for clinicians. Int. J. Infect. Dis. 105, 505\u2013515 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"1281_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04889-x","volume":"7","author":"JW Golden","year":"2017","unstructured":"Golden, J. W. et al. An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection. Sci. Rep. 7, 4679 (2017).","journal-title":"Sci. Rep."},{"key":"1281_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.antiviral.2019.01.006","volume":"163","author":"A Leske","year":"2019","unstructured":"Leske, A. et al. Assessing cross-reactivity of Jun\u00edn virus-directed neutralizing antibodies. Antiviral Res. 163, 106\u2013116 (2019).","journal-title":"Antiviral Res."},{"key":"1281_CR35","doi-asserted-by":"publisher","first-page":"102001","DOI":"10.1016\/j.tmaid.2021.102001","volume":"40","author":"CR Silva-Ramos","year":"2021","unstructured":"Silva-Ramos, C. R., Faccini-Mart\u00ednez, \u00c1. A., Calixto, O.-J. & Hidalgo, M. Bolivian hemorrhagic fever: a narrative review. Travel Med. Infect. Dis. 40, 102001 (2021).","journal-title":"Travel Med. Infect. Dis."},{"key":"1281_CR36","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.tmaid.2020.101589","volume":"36","author":"JP Escalera-Antezana","year":"2020","unstructured":"Escalera-Antezana, J. P. et al. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: a cluster analysis. Travel Med. Infect. Dis. 36, 101589 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"1281_CR37","doi-asserted-by":"publisher","first-page":"100945","DOI":"10.1016\/j.nmni.2021.100945","volume":"44","author":"AJ Rodr\u00edguez-Morales","year":"2021","unstructured":"Rodr\u00edguez-Morales, A. J., Bonilla-Aldana, D. K., Risquez, A., Paniz-Mondolfi, A. & Su\u00e1rez, J. A. Should we be concerned about Venezuelan hemorrhagic fever?\u2014A reflection on its current situation in Venezuela and potential impact in Latin America amid the migration crisis. New Microbes New Infect. 44, 100945 (2021).","journal-title":"New Microbes New Infect."},{"key":"1281_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/0037-8682-0330-2016","volume":"50","author":"JH Ellwanger","year":"2017","unstructured":"Ellwanger, J. H. & Chies, J. A. B. Keeping track of hidden dangers\u2014the short history of the Sabi\u00e1 virus. Rev. Soc. Bras. Med. Trop. 50, 3\u20138 (2017).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"1281_CR39","doi-asserted-by":"publisher","first-page":"317ps24","DOI":"10.1126\/scitranslmed.aad3106","volume":"7","author":"D Medaglini","year":"2015","unstructured":"Medaglini, D., Harandi, A. M., Ottenhoff, T. H. M. & Siegrist, C.-A. Ebola vaccine R&D: filling the knowledge gaps. Sci. Transl. Med. 7, 317ps24 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1281_CR40","doi-asserted-by":"publisher","first-page":"e02650","DOI":"10.1128\/mbio.02650-21","volume":"13","author":"WM Ng","year":"2022","unstructured":"Ng, W. M. et al. Contrasting modes of New World arenavirus neutralization by immunization-elicited monoclonal antibodies. mBio 13, e0265021 (2022).","journal-title":"mBio"},{"key":"1281_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04271-z","volume":"9","author":"LE Clark","year":"2018","unstructured":"Clark, L. E. et al. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses. Nat. Commun. 9, 1884 (2018).","journal-title":"Nat. Commun."},{"key":"1281_CR42","doi-asserted-by":"publisher","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","volume":"11","author":"R Sommerstein","year":"2015","unstructured":"Sommerstein, R. et al. Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection. PLoS Pathog. 11, e1005276 (2015).","journal-title":"PLoS Pathog."},{"key":"1281_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.virol.2010.10.011","volume":"409","author":"CJ Bonhomme","year":"2011","unstructured":"Bonhomme, C. J. et al. Glycosylation modulates arenavirus glycoprotein expression and function. Virology 409, 223\u2013233 (2011).","journal-title":"Virology"},{"key":"1281_CR44","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1128\/JVI.00526-15","volume":"89","author":"C Huang","year":"2015","unstructured":"Huang, C. et al. Highly pathogenic New World and Old World human arenaviruses induce distinct interferon responses in human cells. J. Virol. 89, 7079\u20137088 (2015).","journal-title":"J. Virol."},{"key":"1281_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/jir.1985.5.383","volume":"5","author":"SC Levis","year":"1985","unstructured":"Levis, S. C. et al. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5, 383\u2013389 (1985).","journal-title":"J. Interferon Res."},{"key":"1281_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4269\/ajtmh.1999.60.85","volume":"60","author":"RF Marta","year":"1999","unstructured":"Marta, R. F. et al. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60, 85\u201389 (1999).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1281_CR47","doi-asserted-by":"publisher","first-page":"e02006-","DOI":"10.1128\/JVI.02006-19","volume":"94","author":"EJ Mateer","year":"2020","unstructured":"Mateer, E. J., Maruyama, J., Card, G. E., Paessler, S. & Huang, C. Lassa virus, but not highly pathogenic New World arenaviruses, restricts immunostimulatory double-stranded RNA accumulation during infection. J. Virol. 94, e02006-19 (2020).","journal-title":"J. Virol."},{"key":"1281_CR48","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537\u2013W544 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1281_CR49","doi-asserted-by":"publisher","first-page":"e00189-","DOI":"10.1128\/mSphere.00189-18","volume":"3","author":"F Amanat","year":"2018","unstructured":"Amanat, F. et al. Antibodies to the glycoprotein GP2 subunit cross-react between Old and New World arenaviruses. mSphere 3, e00189-18 (2018).","journal-title":"mSphere"},{"key":"1281_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.21105\/joss.00352","volume":"2","author":"T Cokelaer","year":"2017","unstructured":"Cokelaer, T., Desvillechabrol, D., Legendre, R. & Cardon, M. \u2018Sequana\u2019: a set of Snakemake NGS pipelines. J. Open Source Softw. 2, 352 (2017).","journal-title":"J. Open Source Softw."},{"key":"1281_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"1281_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1281_CR53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1281_CR54","unstructured":"Baize, S. The MOPEVAC multivalent vaccine induces sterile protection against New World Arenaviruses non-human primates. Zenodo https:\/\/zenodo.org\/record\/7229439 (2022)."},{"key":"1281_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01281-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:56:32Z","timestamp":1733957792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01281-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1038\/s41564-022-01281-y","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The MOPEVAC vaccine platform described in this study is protected by US patent 62\/245,631; the authors listed as co-inventors are S.R., S. Baize, X.C., M. Mateo and A.J.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}